AngioSafe Leadership
Backed by >200 additional years of engineering, clinical, nonclinical, manufacturing experience
- AngioSafe co-founder, Investor, and Board Member
- AngioSafe Board Chairman (2015-2025)
- Seasoned Silicon Valley investor, entrepreneur, global company builder
- President and CEO, Co-founder, Investor, Board Member
- Built Pearl Therapeutics to a $1.15B acquisition by AstraZeneca
- Deep experience in drug and device combination field
- Founder, Head of Innovation at AngioSafe, Board Member
- General surgery, practicing endovascular physician
- A blend of interventional and engineering knowledge
- Founder and Managing Partner, Ananta Ventures
- Angiosafe Board Member
- Board Member, Pharmanova and Atlantic Lifesciences
